Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial

Journal article

Sharma P. et al, (2019), Journal of Clinical Oncology, 37, 3484 - 3492

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study

Journal article

McCain RS. et al, (2019), Cancer Causes & Control, 31, 1 - 11

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

Journal article

Parkes EE. et al, (2016), Journal of the National Cancer Institute, 109, djw199 - djw199

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer

Journal article

Buckley NE. et al, (2016), Oncotarget, 7, 19884 - 19896